BIA Separations has 20 years’ experience in chromatographic purification. Our products, CIM monoliths, were designed with unique operating properties that make them ideally suited to the challenging requirements of purifying biomolecules such as virus particles, vesicles, proteins, RNA’s, plasmids and other forms of DNA. We provide products that range from small analytical columns to large industrial prep-scale columns (including cGMP and disposable units) as well as method development services.
Patheon Viral Vector Services
Thermo Fisher Scientific provides industry-leading solutions for drug development, clinical trial logistics and commercial manufacturing to customers through our Patheon brand. Our Patheon Viral Vector Services business (formerly Brammer Bio) specializes in CDMO services for companies developing gene-modified cell therapies and in vivo gene therapies.Our key offerings include process and analytical development, clinical and commercial supply of viral vector drug substance and drug product, and regulatory support, enabling our clients to bring novel medicines to market.We are flexible to support every client’s unique product needs, timelines and regulatory pathways. Through recent investments in our world-class facilities and planned expansions, we are strategically positioned to support your immediate and long-term viral vector manufacturing needs.
The Jackson Laboratory
The Jackson Laboratory is the definitive resource for uncovering the genetic and molecular causes of genetic diseases. With ever-increasing precision, JAX® Mice, Clinical & Research Services provides the most innovative and unparalleled mouse models and research services, supporting the transition from discovery to application, resulting in individualized treatments and therapies.
Veristat is a CRO with a focus in accelerating clients’ rare disease therapies for unmet medical needs through the clinical development process. We've worked on more than 300 rare disease clinical projects and have prepared over 35 rare disease regulatory submissions. With experience in running trials for the first gene therapy approved in Europe, and over 20 gene therapy trials, Veristat is adept in providing comprehensive solutions for Advanced Therapies.
MolMed is a biotech company focused on innovative cell and gene therapies that can meet the therapeutic needs in the treatment of tumors and rare diseases, by combining scientific and research excellence with clear and strong industrial projects. With two approved manufacturing facilities (about 4.800 SQM) and top level expertise, MolMed offers platforms of lentiviral and retroviral vector manufacturing with different scales and a consolidated processes in cells engineering (Hematopoietic Stem cells and T-cells).